Improving glucose tolerance in obese rats:the role of Jinlida granules(津力达颗粒)in gut microbiota modulationOA
Improving glucose tolerance in obese rats:the role of Jinlida granules(津力达颗粒)in gut microbiota modulation
LI Dongqi;MENG Yongjie;ZHANG Zeyu;HOU Yunlong;GAO Huailin;WANG Tongxing;WANG Zixuan;YAN Yihui;LI Jie;GU Jiaojiao;LI Cuiru;WANG Aili;SUN Lingling
Graduate School,Hebei University of Chinese Medicine,Shijiazhuang 050090,ChinaGraduate School,Hebei University of Chinese Medicine,Shijiazhuang 050090,ChinaGraduate School,Hebei University of Chinese Medicine,Shijiazhuang 050090,ChinaNational Key Laboratory for Innovation and Transformation of Luobing Theory,Shijiazhuang 050035,China||Hebei Yiling Pharmaceutical Research Institute,Key Laboratory of State Administration of TCM(Cardio-Cerebral Vessel Collateral Diseases),Shijiazhuang 050035,ChinaGraduate School,Hebei University of Chinese Medicine,Shijiazhuang 050090,China||Endocrinology Department,Hebei Yiling Hospital,Shijiazhuang 050091,ChinaNational Key Laboratory for Innovation and Transformation of Luobing Theory,Shijiazhuang 050035,China||Hebei Yiling Pharmaceutical Research Institute,Key Laboratory of State Administration of TCM(Cardio-Cerebral Vessel Collateral Diseases),Shijiazhuang 050035,ChinaGraduate School,Hebei Medical University,Shijiazhuang 050017,ChinaGraduate School,Hebei University of Chinese Medicine,Shijiazhuang 050090,ChinaGraduate School,Hebei University of Chinese Medicine,Shijiazhuang 050090,ChinaGraduate School,Hebei University of Chinese Medicine,Shijiazhuang 050090,ChinaGraduate School,Hebei University of Chinese Medicine,Shijiazhuang 050090,ChinaDepartment of Medical Oncology,Hebei Yiling Hospital,Shijiazhuang 050091,ChinaGraduate School,Henan University of Traditional Chinese Medicine,Zhengzhou 450046,China
Jinlida granulesobesitygut microbiotaintestinal barrierintestinal inflammationglucose tolerance
Jinlida granulesobesitygut microbiotaintestinal barrierintestinal inflammationglucose tolerance
《中医杂志（英文版）》 2026 (1)
62-72,11
Supported by the National Key Research and Development Program'Modernization Research of Traditional Chinese Medicine':Cardiovascular Event Chain(Metabolic Syndrome,Atherosclerosis,Myocardial Infarction,Arrhythmia,Heart Failure)(No.2017YFC700500)the Key R&D Program of Hebei:Traditional Chinese Medicine Innovation Project:Clinical Research on the Treatment of Diabetes Foot with Collateral Drugs and the Mechanism of Its Influence on Collateral Vessel Reconstruction(No.223777155D)the Scientific Research Project of Hebei Provincial Administration of Traditional Chinese Medicine:Clinical Study on Jinlida Granules in Treating Intestinal Dysfunction of diabetes and Its Effect on Short Chain Fatty Acids(No.2023179)and the Scientific Research Project of Hebei Provincial Administration of Traditional Chinese Medicine:Clinical Study on Tongluo Therapy for Diabetes Foot and Its Influence on Microcirculation(No.2018200)
评论